RecruitingNot ApplicableNCT07187297

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment to Improve Lines and Wrinkles and to Lift and Tighten Lax Tissue in the Neck, Abdomen, Upper Arms, and Face

Sponsor

Bausch Health Americas, Inc.

Enrollment

164 participants

Start Date

Oct 31, 2025

Study Type

INTERVENTIONAL

Conditions

Wrinkle Lax Skin Lines Skin

Summary

A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System

Eligibility

Min Age: 30 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Thermage FLX for people with lax skin, lines skin, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 30 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEThermage FLX

The Thermage FLX System ('System') is a monopolar, capacitively coupled radiofrequency System designed for use in non-invasive dermatological procedures